Home > Balance Sheet > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Contingent Liabilities

    Back to Balance Sheet
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

SYNCOM FORMULATIONS (INDIA) Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Contingent Liabilities ₹0.86 Cr₹0.55 Cr₹0.55 Cr₹0.55 Cr₹2.74 Cr

What is the latest Contingent Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Contingent Liabilities ratio of SYNCOM FORMULATIONS (INDIA) is ₹0.86 Cr based on Mar2025 Consolidated results.
Year Contingent Liabilities
Mar2025₹0.86 Cr
Mar2024₹0.55 Cr
Mar2023₹0.55 Cr
Mar2022₹0.55 Cr
Mar2017₹2.74 Cr

How is Contingent Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?

Years Contingent Liabilities % Change
Mar2025 ₹0.86 Cr
56.18
Mar2024 ₹0.55 Cr
0.00
Mar2023 ₹0.55 Cr
0.00
Mar2022 ₹0.55 Cr
-79.96
Mar2017 ₹2.74 Cr -

Compare Contingent Liabilities of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,200.4 Cr -4.1% -0.8% -24.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,028.0 Cr 0.3% 9% 8.6% Stock Analytics
DIVIS LABORATORIES ₹170,237.0 Cr 1.9% 5.9% 12.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,801.0 Cr 0.6% 9.5% 45% Stock Analytics
CIPLA ₹108,861.0 Cr 1.6% 1.8% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹107,435.0 Cr -1.5% 5.7% 14.5% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-4.1%

-0.8%

-24.5%

SENSEX

-1.8%

-1.6%

7.3%


You may also like the below Video Courses